International Stem Cell Corporation announced that its oocyte collection and activation protocol has received the approval of an Institutional Review Board, a Federal requirement for all studies enrolling human subjects, and ensures appropriate subj
Read MoreDr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica's allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the Uni
Read MoreInternational Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company's development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are
Read MoreInternational Stem Cell Corporation, an international pioneer and leader in stem cell research, announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is m
Read MoreA quick education on the difference between embryonic stem cells and adult stem cells. Adult Stem Cells were present in our bodies before the day we were born and are the natural process of how our bodies renew and rejuvenate themselves on daily.
Read MoreThe ICMS announces the publication of the largest stem cell safety study. Using the guidelines put forward by the ICMS, 227 patients were tracked after receiving adult stem cell therapies using a novel new protocol with no reported complications.
Read More